125 related articles for article (PubMed ID: 8669475)
1. Immunolocalization and gene expression of oxytocin receptors in carcinomas and non-neoplastic tissues of the breast.
Bussolati G; Cassoni P; Ghisolfi G; Negro F; Sapino A
Am J Pathol; 1996 Jun; 148(6):1895-903. PubMed ID: 8669475
[TBL] [Abstract][Full Text] [Related]
2. Oxytocin receptors in human adenocarcinomas of the endometrium: presence and biological significance.
Cassoni P; Fulcheri E; Carcangiu ML; Stella A; Deaglio S; Bussolati G
J Pathol; 2000 Mar; 190(4):470-7. PubMed ID: 10699997
[TBL] [Abstract][Full Text] [Related]
3. Localization of thrombospondin and its cysteine-serine-valine-threonine-cysteine-glycine-specific receptor in human breast carcinoma.
Tuszynski GP; Nicosia RF
Lab Invest; 1994 Feb; 70(2):228-33. PubMed ID: 7511188
[TBL] [Abstract][Full Text] [Related]
4. Oxytocin receptor within the breast: biological function and distribution.
Sapino A; Cassoni P; Stella A; Bussolati G
Anticancer Res; 1998; 18(3C):2181-6. PubMed ID: 9703781
[TBL] [Abstract][Full Text] [Related]
5. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
de Candia P; Akram M; Benezra R; Brogi E
Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
[TBL] [Abstract][Full Text] [Related]
6. Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast.
Clezardin P; Frappart L; Clerget M; Pechoux C; Delmas PD
Cancer Res; 1993 Mar; 53(6):1421-30. PubMed ID: 7680285
[TBL] [Abstract][Full Text] [Related]
7. Evidence of oxytocin/oxytocin receptor interplay in human prostate gland and carcinomas.
Cassoni P; Marrocco T; Sapino A; Allia E; Bussolati G
Int J Oncol; 2004 Oct; 25(4):899-904. PubMed ID: 15375538
[TBL] [Abstract][Full Text] [Related]
8. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.
Kominsky SL; Argani P; Korz D; Evron E; Raman V; Garrett E; Rein A; Sauter G; Kallioniemi OP; Sukumar S
Oncogene; 2003 Apr; 22(13):2021-33. PubMed ID: 12673207
[TBL] [Abstract][Full Text] [Related]
9. Oxytocin is a growth factor for Kaposi's sarcoma cells: evidence of endocrine-immunological cross-talk.
Cassoni P; Sapino A; Deaglio S; Bussolati B; Volante M; Munaron L; Albini A; Torrisi A; Bussolati G
Cancer Res; 2002 Apr; 62(8):2406-13. PubMed ID: 11956104
[TBL] [Abstract][Full Text] [Related]
10. Expression and localization of human oxytocin receptor mRNA and its protein in chorion and decidua during parturition.
Takemura M; Kimura T; Nomura S; Makino Y; Inoue T; Kikuchi T; Kubota Y; Tokugawa Y; Nobunaga T; Kamiura S
J Clin Invest; 1994 Jun; 93(6):2319-23. PubMed ID: 8200965
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 gene amplification and protein expression in benign breast disease and breast carcinoma.
Zhu XL; Hartwick W; Rohan T; Kandel R
Mod Pathol; 1998 Nov; 11(11):1082-8. PubMed ID: 9831206
[TBL] [Abstract][Full Text] [Related]
12. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
[TBL] [Abstract][Full Text] [Related]
13. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
[TBL] [Abstract][Full Text] [Related]
14. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of keratins 13 and 16 in normal epithelium, benign lesions, and ductal carcinomas of the human breast determined by the monoclonal antibody Ks8.12.
Pellegrino MB; Asch BB; Connolly JL; Asch HL
Cancer Res; 1988 Oct; 48(20):5831-6. PubMed ID: 2458830
[TBL] [Abstract][Full Text] [Related]
16. HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.
Krop IE; Sgroi D; Porter DA; Lunetta KL; LeVangie R; Seth P; Kaelin CM; Rhei E; Bosenberg M; Schnitt S; Marks JR; Pagon Z; Belina D; Razumovic J; Polyak K
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9796-801. PubMed ID: 11481438
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA
Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139
[TBL] [Abstract][Full Text] [Related]
18. Oxytocin synthesis within the normal and neoplastic breast: first evidence of a local peptide source.
Cassoni P; Marrocco T; Sapino A; Allia E; Bussolati G
Int J Oncol; 2006 May; 28(5):1263-8. PubMed ID: 16596243
[TBL] [Abstract][Full Text] [Related]
19. A plasmin-derived hexapeptide from the carboxyl end of osteocalcin counteracts oxytocin-mediated growth inhibition [corrected] of osteosarcoma cells.
Novak JF; Judkins MB; Chernin MI; Cassoni P; Bussolati G; Nitche JA; Nishimoto SK
Cancer Res; 2000 Jul; 60(13):3470-6. PubMed ID: 10910058
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
Van den Eynden GG; Van Laere SJ; Van der Auwera I; Merajver SD; Van Marck EA; van Dam P; Vermeulen PB; Dirix LY; van Golen KL
Breast Cancer Res Treat; 2006 Feb; 95(3):219-28. PubMed ID: 16244790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
